EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Simultaneous Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Patients with BRCA1 and BRCA2 Pathogenic Variants: A Single-Center Retrospective Cohort Study

Raquel Diaz iD, Federica Murelli, Franco Alessandri, Maria Grazia Centurioni, Fabio Barra iD, Letizia Cuniolo, Rebecca Allievi, Abdallah Saad, Chiara Cornacchia, Francesca Depaoli, Cecilia Margarino, Ludovico Ponzielli iD und 9 weitere

Journal of Personalized Medicine · 30.05.2026 · 16 (6) · 295

DOI: 10.3390/jpm16060295 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Personalized Medicine, online erschienen am 30.05.2026. Verfasst von Raquel Diaz und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Diagnostic Integrated Sciences-DISC, University of Genova, 16132 Genova, Italy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Women carrying BRCA1 and BRCA2 pathogenic variants face a substantially increased lifetime risk of breast and ovarian cancer. Risk-reducing bilateral mastectomy and salpingo-oophorectomy are well-established strategies to lower this risk. Traditionally, these procedures are performed in separate surgical sessions; however, a simultaneous approach may reduce the overall treatment burden. Evidence regarding the safety and feasibility of combined procedures remains limited.

Methods

We conducted a retrospective observational study of BRCA1 and BRCA2 pathogenic variant carriers who underwent risk-reducing or therapeutic breast surgery at the Breast Unit of Policlinico San Martino Hospital (Genova, Italy) between January 2013 and March 2025. Patients were divided into two groups according to surgical strategy: a simultaneous procedure group undergoing risk-reducing mastectomy with immediate breast reconstruction and concurrent salpingo-oophorectomy in a single operative session, and a staged procedure group undergoing the same interventions in separate surgeries. Demographic, surgical, and postoperative variables were collected and analyzed descriptively.

Results

A total of 124 BRCA1 and BRCA2 pathogenic variant carriers were included, with 73 patients undergoing the simultaneous approach and 51 undergoing staged procedures. The mean age was similar between the Simultaneous and Staged Procedure Groups Descriptively, similar patterns were observed across the two groups in terms of age distribution, postoperative outcomes, and length of hospital stay (mean 4.56 days). Minor complications such as seroma or delayed wound healing showed similar patterns across both groups, with no apparent increase in major complications in the simultaneous surgery group. Patients undergoing the simultaneous approach required fewer surgical sessions and were exposed to general anesthesia only once.

Conclusions

Simultaneous risk-reducing mastectomy with immediate reconstruction and salpingo-oophorectomy appears to be a safe and feasible strategy for selected BRCA1 and BRCA2 pathogenic variant carriers. This integrated surgical approach may reduce the overall surgical burden, with descriptively similar perioperative outcome patterns.

Schlagwörter

Stichwörter der Autor:innen

BRCA1BRCA2hereditary breast and ovarian cancerpathogenic variantsrisk-reducing mastectomysalpingo-oophorectomy

Autor:innen und Institutionen

  • Department of Surgical and Diagnostic Integrated Sciences-DISC, University of Genova, 16132 Genova, Italy.
  • Breast Surgery, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Plastic Surgery Division, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Department of Medical Oncology, Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

ORCID-Profile: Raquel Diaz, Fabio Barra, Ludovico Ponzielli, Elisa Bertulla, Ilaria Baldelli, Lucia Trevisan, Piero Fregatti

Zitieren

APA

Diaz, R., Murelli, F., Alessandri, F., Centurioni, M. G., Barra, F., Cuniolo, L., Allievi, R., Saad, A., Cornacchia, C., Depaoli, F., Margarino, C., Ponzielli, L., Bertulla, E., Boccardo, C., Baldelli, I., Leone, M. S., Adami, M., Franchelli, S., Pesce, M., …, & Fregatti, P. (2026). Simultaneous Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Patients with BRCA1 and BRCA2 Pathogenic Variants: A Single-Center Retrospective Cohort Study. Journal of Personalized Medicine, 16(6), 295. https://doi.org/10.3390/jpm16060295

Vancouver

Diaz R, Murelli F, Alessandri F, Centurioni MG, Barra F, Cuniolo L, et al. Simultaneous Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Patients with BRCA1 and BRCA2 Pathogenic Variants: A Single-Center Retrospective Cohort Study. Journal of Personalized Medicine. 2026;16(6):295. doi:10.3390/jpm16060295

BibTeX
@article{Diaz2026,
  author = {Diaz, Raquel and Murelli, Federica and Alessandri, Franco and Centurioni, Maria Grazia and Barra, Fabio and Cuniolo, Letizia and Allievi, Rebecca and Saad, Abdallah and Cornacchia, Chiara and Depaoli, Francesca and Margarino, Cecilia and Ponzielli, Ludovico and Bertulla, Elisa and Boccardo, Chiara and Baldelli, Ilaria and Leone, Maria Stella and Adami, Michaela and Franchelli, Simonetta and Pesce, Marianna and Trevisan, Lucia and Fregatti, Piero},
  title = {Simultaneous Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Patients with BRCA1 and BRCA2 Pathogenic Variants: A Single-Center Retrospective Cohort Study},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {295},
  doi = {10.3390/jpm16060295}
}
Kostenlos starten →